Literature DB >> 31847615

First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation.

Phue Khaing1, Arpana Paruchuri2, John R Eisenbrey3, Geno J Merli4, Carin F Gonsalves5, Frances M West1, Bharat K Awsare1.   

Abstract

Objectives: The Pulmonary Embolism Response Team (PERT) model is now widely adopted in many institutions to provide multidisciplinary care for patients with acute pulmonary embolism (PE). However, descriptive experiences of PERT operations and studies on clinical outcomes remain limited.
Methods: We performed a retrospective review of PERT activations at an academic tertiary care center, with secondary aims to study outcomes associated with performing catheter directed therapies (CDT).
Results: The intermediate high-risk PE category was most frequent (n = 40, 76.9%) among the 52 total cases evaluated during the study period. There was one in-hospital mortality, associated with hospice admission for a non-PE diagnosis. Six patients (11.5%) experienced a bleeding complication of any severity. Anticoagulation (AC) alone was recommended in 30 patients (57.7%) and CDT was performed in 16 patients (30.8%). There were no significant differences in patient characteristics or disease severity between patients in the AC group versus the CDT group, except for a higher prevalence of malignancy in the AC group (p = 0.037). Patients who underwent CDT demonstrated a lower, albeit non-significant, median intensive care unit (ICU) length of stay (LOS) (3 vs. 4 days, p = 0.34) and hospital LOS (4 vs. 5 days, p = 0.25), as compared to patients receiving AC alone. Bleeding rates were similar between the two groups (6.7% vs. 6.3%, p = 1.0).Conclusions: Adoption of the PERT model at an academic tertiary care center was associated with acceptably low rates of mortality and bleeding, similar to other published studies. Performing CDT in select patients under PERT consultation may be associated with shorter ICU and hospital LOS; however, larger studies are needed to validate this finding.

Entities:  

Keywords:  Pulmonary embolism; anticoagulation; catheter directed thrombolysis; length of stay; pulmonary embolism response team

Mesh:

Substances:

Year:  2020        PMID: 31847615     DOI: 10.1080/21548331.2020.1706315

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  3 in total

1.  Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.

Authors:  Arkadiusz Pietrasik; Aleksandra Gąsecka; Łukasz Szarpak; Michał Pruc; Tomasz Kopiec; Szymon Darocha; Marta Banaszkiewicz; Maciej Niewada; Marcin Grabowski; Marcin Kurzyna
Journal:  Front Cardiovasc Med       Date:  2022-06-16

2.  Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis.

Authors:  Lukas Hobohm; Ioannis T Farmakis; Karsten Keller; Barbara Scibior; Anna C Mavromanoli; Ingo Sagoschen; Thomas Münzel; Ingo Ahrens; Stavros Konstantinides
Journal:  Clin Res Cardiol       Date:  2022-08-17       Impact factor: 6.138

3.  Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience.

Authors:  Arkadiusz Pietrasik; Aleksandra Gąsecka; Paweł Kurzyna; Katarzyna Wrona; Szymon Darocha; Marta Banaszkiewicz; Dariusz Zieliński; Dominika Zajkowska; Julia Maria Smyk; Dominika Rymaszewska; Karolina Jasińska; Marcin Wasilewski; Rafał Wolański; Grzegorz Procyk; Piotr Szwed; Michał Florczyk; Krzysztof Wróbel; Marcin Grabowski; Adam Torbicki; Marcin Kurzyna
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.